key: cord-1050522-hjsy7gez authors: Kulle, Cemil Burak; Azamat, Ibrahim Fethi; Vatansever, Dogan; Erus, Suat; Tarim, Kayhan; Akyoldas, Goktug; Gokler, Ozan; Deveci, Mehmet Ali; Cakar, Nahit; Ergonul, Onder; Agcaoglu, Orhan; Kiremit, Murat Can; Yavuz, Omer; Kiris, Talat; Unsaler, Selin; Giray, Burak; Korkmaz, Murat; Dilege, Ece; Kilic, Mert; Cesur, Ezgi; Solaroglu, Ihsan; Altuntas, Ozan; Simsek, Aykin; Tanju, Serhan; Erkan, Mert; Canda, Erdem; Sasani, Mehdi; Hafiz, Aysenur Meric; Kordan, Yakup; Balik, Emre; Bilge, Orhan; Bugra, Dursun; Taskiran, Cagatay; Dilege, Sukru title: Is elective cancer surgery feasible during the lock‐down period of the COVID‐19 pandemic? Analysis of a single institutional experience of 404 consecutive patients date: 2021-02-23 journal: J Surg Oncol DOI: 10.1002/jso.26436 sha: d022a11da5cd85fe63c8a1a748129495de0fe07d doc_id: 1050522 cord_uid: hjsy7gez BACKGROUND: We aimed to assess the feasibility and short‐term clinical outcomes of surgical procedures for cancer at an institution using a coronavirus disease 2019 (COVID‐19)‐free surgical pathway during the peak phase of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic. MATERIALS AND METHODS: This was a single‐center study, including cancer patients from all surgical departments, who underwent elective surgical procedures during the first peak phase between March 10 and June 30, 2020. The primary outcomes were the rate of postoperative SARS‐CoV‐2 infection and 30‐day pulmonary or non‐pulmonary related morbidity and mortality associated with SARS‐CoV‐2 disease. RESULTS: Four hundred and four cancer patients fulfilling inclusion criteria were analyzed. The rate of patients who underwent open and minimally invasive procedures was 61.9% and 38.1%, respectively. Only one (0.2%) patient died during the study period due to postoperative SARS‐CoV2 infection because of acute respiratory distress syndrome. The overall non‐SARS‐CoV2 related 30‐day morbidity and mortality rates were 19.3% and 1.7%, respectively; whereas the overall SARS‐CoV2 related 30‐day morbidity and mortality rates were 0.2% and 0.2%, respectively. CONCLUSIONS: Under strict institutional policies and measures to establish a COVID‐19‐free surgical pathway, elective and emergency cancer operations can be performed with acceptable perioperative and postoperative morbidity and mortality. The SARS-CoV-2 pandemic caused a paradigm shift worldwide and had tremendous effects on the healthcare system. Since the beginning of the SARS-Cov2 pandemic, cancer patients' treatment has become more challenging. More than two million cancer operations were postponed or cancelled due to in-hospital cross-infection risk. 2 Shortly after the pandemic's surge, it was well understood that COVID-19 was associated with higher perioperative pulmonary complications leading to increased morbidity and mortality. 3 screening policies, operative room settings, personal protective equipment (PPE), and postoperative care, were adapted according to surgical societies' guidelines. 5, 6 We aimed to assess the feasibility and short-term clinical outcomes of cancer operations by evaluating patients from all surgical departments on a consecutive basis using a COVID-19-free surgical pathway during the peak phase of the SARS-CoV-2 pandemic at a high-volume institution. All patients undergoing surgical procedures for cancer were included. A surgical procedure was defined as any procedure done by a surgeon in an operating theatre under local, regional or general anaesthesia based on oncological principles. Patients were preoperatively identified and discussed among a multidisciplinary team at the weekly institutional tumor board and subsequently scheduled for operation. Patients were followed up to postoperative day 30, with the day of operation defined as the beginning (Day 0 Data were collected retrospectively including demographic variables (age, sex, comorbidities, and American Society of Anesthesiologists [ASA] Score), preoperative workup regarding COVID-19 (symptoms, polymerase chain reaction [PCR] , and/or chest computed tomography (CT) scan), the urgency of surgical procedure (elective or emergency), type of anaesthesia (local, regional or general), surgical technique (minimally invasive procedure or open procedure), cancer types, operation time, perioperative morbidity-mortality, and characteristics of postoperative care (postoperative complications, need for reoperation, admission and length of stay at intensive care unit, readmission to intensive care unit, length of stay at the hospital and postoperative mortality and morbidity related to COVID-19 infection). Data were collected from our electronic database, and patients were contacted via video-teleconference when there was a need for additional information missing in the institutional database. The primary outcome was the COVID-19 related intraoperative, perioperative or postoperative morbidity and mortality. All medical staff used surgical masks, gloves, and bonnets appropriately. When a COVID-19 positive or a suspected patient is encountered, extra precautions have been taken to keep in a PPE that provides a high level of protection, including a disposable N95 respirator, double-layer gloves, face shield, goggles, safety shoes, and surgical dress to achieve full protection measures. All patients and medical staff had to wear surgical masks during the preoperative follow-ups, and patients' physical examinations were performed with disposable latex gloves. In our institution, a single-use PPE was never re-used neither by our patients nor the healthcare professionals. Patient rooms, ICU beds, and recovery rooms were re-designed. Standard patient rooms were provided with vital sign monitors, oxygen support systems, and noninvasive ventilatory support equipment to decrease ICU demand. The number of ICU beds has been increased by converting the recovery rooms to ICU. In the end, we had two fully equipped ICUs, one for SARS-CoV2 negative and the other for SARS-CoV2 positive or suspicious patients. The main aim was to create SARS-CoV2-free surgical pathways. Regional anaesthesia was the first choice, if possible. However, if general anaesthesia was inevitable, the intubation was performed by an experienced anesthesiologist with a rapid sequence technique using a video-laryngoscope. Only the nurse, anesthesiology specialist, and anesthesiology technician were allowed to be present in the room during the procedure. During the operation, adequate viral filters were applied to the ventilator circuit without disconnection. The patient was extubated in the operating room and sent to the patient ward after full recovery. Special precautions were taken for minimally invasive procedures such as laparoscopic and robotic procedures to mitigate the risk of COVID-19 infection during these procedures. All of these surgical procedures were performed in negative pressure operating theatres with a minimum number of surgeons, surgical nurses, and personnel. The insufflation pressures were set to low intraperitoneal pressures (8-10 mmHg), and low flow rates (5-10 L/min of CO 2 ) were preferred. The incision length at trocar sites was minimized, the trocars were placed as perpendicular as possible to the abdominal fascia, and any trocar removal or replacement was avoided until the end of the operation. The use of electrosurgical instruments such as vessel sealing devices, ultrasonic devices, and harmonic scalpels was avoided to decrease the amount of smoke created. The smoke was evacuated through one of the ports connected directly to the suction system without any leakage. After the procedures, the pathological specimens were secured for subsequent removal. The insufflation port was closed, and the smoke evacuation port was kept open until all the intra-abdominal CO 2 deflated utterly. A total of four hundred and four patients were diagnosed with cancer and underwent radical surgical procedures. A 30-day surveillance period was achieved for all patients (100.0%). The median KULLE ET AL. | 3 age of the cohort was 61 years (range, 2-91 years). Of the 404 cases, 232 (57.5%) had coexisting comorbidities. Hypertension was reported in 133 (32.9%) patients, diabetes mellitus in 47 (11.6%), coronary heart disease in 45 (11.1%), and chronic obstructive pulmonary disease in 19 (4.7%). One hundred thirty-nine (34.4%) patients were current tobacco smokers. The ASA scores were I, II, III, and IV in 53 (13.2%), 238 (58.9%), 95 (23.6%), and 18 (4.3%) patients, respectively. Baseline characteristics of the patients are given in Table 1 . Ninety-eight patients (24.3%) who did not have any suspicious finding, did not undergo any further testing during the first period. Only nasal/oropharyngeal swab testing was performed in five patients (1.2%), only chest CT was performed in 68 (16.8%), and the combination of a swab test and chest CT were performed in 233 patients (57.7%) ( Table 2) . Table 3 outlines the surgical variables during the study period. The distribution of cancer types among patients who underwent radical surgical procedures were as follows: breast 19 (4.7%), en- (Table 3) . as I, 29 (7.1%) as II, 32 (7.9%) as III, 2 (0.5%) as IV, and 5 (1.2%) patients as V (Table 4) . Hospital, median (range), days 6 (0-57) refusal. In particular, many survey-based studies reported that surgeons tend to delay cancer operations, and they tend to replace surgical procedures with chemotherapy and/or radiotherapy if possible. 8, 9 However, patients diagnosed with cancer are more susceptible to infections because of the immunosuppressive state induced by the underlying disease and applied adjuvant therapies. 10 These issues should be balanced against the risk of inevitable disease progression in cancer patients. [11] [12] [13] There is a universal consensus that patients with emergent cases such as perforation, bleeding or obstruction must undergo urgent operations. These patients must be treated as SARS-CoV2-positive patients until proven otherwise. During the earlier period of the pandemic, several guidelines, The crucial importance of establishing COVID- This study aimed to investigate the effectiveness of SARS-CoV2 protection measurements and clinical outcomes of cancer patients during the first wave of the pandemic. It is shown that with strict institutional policies and measures taken against COVID-19 infection, elective and emergency cancer operations were feasible with acceptable perioperative and postoperative morbidity and mortality. Additionally, minimally invasive procedures (laparoscopy and robotic) and endoscopic procedures (cystoscopy) can be performed safely. This study showed that COVID-19-free surgical pathways were the essential factor for achieving the best outcomes in the era of the SARS-Cov2 pandemic. There are two main strengths of the current study: first, all of the cancer patients surgically treated by different surgical specialties at a single institution were consecutively included in the study, and the second, the vast majority of the patients underwent major cancer operations during the peak phase of the SARS-CoV2 pandemic. However, these findings should be interpreted with caution. This is a small cohort study with a comparably short follow-up period investigating SARS-CoV2, a new disease that we discover new findings and effects each day. To the best of our knowledge, this is one of the first and the largest series of the single-center experience of patients who underwent radical cancer operations in a wide variety of surgical departments during the COVID-19 pandemic era. We believe that the present study will provide insight into the cancer centers where primary, secondary or tertiary COVID-19 pandemic outbreaks might occur in the future. Data available upon request. Dogan Vatansever http://orcid.org/0000-0002-7831-7070 WHO Director-General's opening remarks at the media briefing on COVID-19 Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Global guidance for surgical care during the COVID-19 pandemic American College of Surgeons COVID-19: Elective Case Triage Guidelines for Surgical Care Scientific Advisory Board Work of the Turkish Ministry of Health: Health Institutions Study Guide and Infection Control Measures during the COVID-19 Pandemic Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: an International, Multicenter, Comparative Cohort Study Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African HepatoPancreato-Biliary Association (E-AHPBA) cross-sectional survey COVID-19 and the global impact on colorectal practice and surgery Mar) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China SSO) Resource for management options of GI and HPB cancers The effect of time from diagnosis to surgery on oncological outcomes in patients undergoing surgery for colon cancer: a systematic review Are we harming cancer patients by delaying their cancer surgery during the COVID-19 pandemic SARS-Cov-2 in peritoneal fluid: an important finding in the COVID-19 pandemic Risks of viral contamination in healthcare professionals during laparoscopy in the COVID-19 pandemic Safe management of surgical smoke in the age of COVID-19 Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery Low risk of contamination with human papillomavirus during treatment of condylomata acuminata with multilayer argon plasma coagulation and CO 2 laser ablation Personal protective equipment and COVID-19-a review for surgeons Clinical characteristics and outcomes of patients un-dergoing surgeries during the incubation period of COVID-19 infection Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Cancer surgery during the COVID-19 pandemic in Turkey Is elective cancer surgery feasible during the lock-down period of the COVID-19 pandemic? Analysis of a single institutional experience of 404 consecutive patients